+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Bioprocess Validation Market Research Report by Test Type, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4829925
  • Report
  • July 2021
  • Region: Global
  • 186 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Bioprocess Validation Market will Grow to USD 597.14 Million by 2026, at a CAGR of 14.59%

FEATURED COMPANIES

  • Almac Group
  • BiOZEEN
  • Doc S.r.l
  • Eurofins Scientific
  • Merck KGaA
  • Pall Corporation
  • MORE
The Global Bioprocess Validation Market size was estimated at USD 263.70 Million in 2020 and expected to reach USD 301.29 Million in 2021, at a Compound Annual Growth Rate (CAGR) 14.59% to reach USD 597.14 Million by 2026.



Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Bioprocess Validation to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Test Type, the Bioprocess Validation Market was examined across Compatibility Testing Services, Extractables/Leachables Testing Services, Integrity Testing Services, and Microbiological Testing Services.
  • Based on Process Component, the Bioprocess Validation Market was examined across Bioreactors, Filter Elements, Freezing and Thawing Process Bags, Media Containers and Bags, Mixing Systems, and Transfer Systems.
  • Based on End User, the Bioprocess Validation Market was examined across Biotechnology Companies, Contract Development & Manufacturing Organizations, and Pharmaceutical Companies.
  • Based on Geography, the Bioprocess Validation Market was examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas was further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific was further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa was further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies this research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Bioprocess Validation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Bioprocess Validation Market, including Almac Group, BiOZEEN, Cobetter Filtration Equipment Co., Ltd., Doc S.r.l, Eurofins Scientific, Hangzhou Anow Microfiltration Co., Ltd., Meissner Filtration Products, Inc., Merck KGaA, Pall Corporation, Porvair plc, Sartorius Stedim Biotech S.A., SGS S.A., Thermo Fisher Scientific, Inc, Tianshan Precision Filter Material Co., Ltd., and Toxikon Corporation.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Bioprocess Validation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Bioprocess Validation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Bioprocess Validation Market?
4. What is the competitive strategic window for opportunities in the Global Bioprocess Validation Market?
5. What are the technology trends and regulatory frameworks in the Global Bioprocess Validation Market?
6. What is the market share of the leading vendors in the Global Bioprocess Validation Market?
7. What modes and strategic moves are considered suitable for entering the Global Bioprocess Validation Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Almac Group
  • BiOZEEN
  • Doc S.r.l
  • Eurofins Scientific
  • Merck KGaA
  • Pall Corporation
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Test Type Outlook
3.4. Process Component Outlook
3.5. End User Outlook
3.6. Geography Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Precise safety and quality regulations
5.1.1.2. Rising demand for biopharmaceuticals
5.1.1.3. Growing need for outsourcing bioprocess validation
5.1.1.4. Increasing life science R&D expenditure
5.1.2. Restraints
5.1.2.1. Issues associated with extractables & leachables
5.1.3. Opportunities
5.1.3.1. Growth opportunities in Asia Pacific and Latin American countries
5.1.3.2. Patent expiry
5.1.4. Challenges
5.1.4.1. Development of new validation methods for next-generation bioproducts
5.1.4.2. Waste disposal
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Bioprocess Validation Market, by Test Type
6.1. Introduction
6.2. Compatibility Testing Services
6.3. Extractables/Leachables Testing Services
6.4. Integrity Testing Services
6.5. Microbiological Testing Services

7. Bioprocess Validation Market, by Process Component
7.1. Introduction
7.2. Bioreactors
7.3. Filter Elements
7.4. Freezing and Thawing Process Bags
7.5. Media Containers and Bags
7.6. Mixing Systems
7.7. Transfer Systems

8. Bioprocess Validation Market, by End User
8.1. Introduction
8.2. Biotechnology Companies
8.3. Contract Development & Manufacturing Organizations
8.4. Pharmaceutical Companies

9. Americas Bioprocess Validation Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Bioprocess Validation Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand

11. Europe, Middle East & Africa Bioprocess Validation Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Almac Group
13.2. BiOZEEN
13.3. Cobetter Filtration Equipment Co., Ltd.
13.4. Doc S.r.l
13.5. Eurofins Scientific
13.6. Hangzhou Anow Microfiltration Co., Ltd.
13.7. Meissner Filtration Products, Inc.
13.8. Merck KGaA
13.9. Pall Corporation
13.10. Porvair plc
13.11. Sartorius Stedim Biotech S.A.
13.12. SGS S.A.
13.13. Thermo Fisher Scientific, Inc
13.14. Tianshan Precision Filter Material Co., Ltd.
13.15. Toxikon Corporation

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2020 (USD MILLION)
FIGURE 3. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2020 (USD MILLION)
FIGURE 4. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 5. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 6. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 7. GLOBAL BIOPROCESS VALIDATION MARKET: MARKET DYNAMICS
FIGURE 8. GLOBAL BIOPROCESS VALIDATION MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 9. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2020 VS 2026 (%)
FIGURE 10. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2026
FIGURE 12. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY COMPATIBILITY TESTING SERVICES, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY COMPATIBILITY TESTING SERVICES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 14. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY EXTRACTABLES/LEACHABLES TESTING SERVICES, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY EXTRACTABLES/LEACHABLES TESTING SERVICES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY INTEGRITY TESTING SERVICES, 2018-2026 (USD MILLION)
FIGURE 17. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY INTEGRITY TESTING SERVICES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 18. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY MICROBIOLOGICAL TESTING SERVICES, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY MICROBIOLOGICAL TESTING SERVICES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2020 VS 2026 (%)
FIGURE 21. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2020 VS 2026 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2026
FIGURE 23. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY BIOREACTORS, 2018-2026 (USD MILLION)
FIGURE 24. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY BIOREACTORS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 25. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY FILTER ELEMENTS, 2018-2026 (USD MILLION)
FIGURE 26. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY FILTER ELEMENTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 27. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY FREEZING AND THAWING PROCESS BAGS, 2018-2026 (USD MILLION)
FIGURE 28. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY FREEZING AND THAWING PROCESS BAGS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 29. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY MEDIA CONTAINERS AND BAGS, 2018-2026 (USD MILLION)
FIGURE 30. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY MEDIA CONTAINERS AND BAGS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 31. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY MIXING SYSTEMS, 2018-2026 (USD MILLION)
FIGURE 32. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY MIXING SYSTEMS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 33. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY TRANSFER SYSTEMS, 2018-2026 (USD MILLION)
FIGURE 34. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY TRANSFER SYSTEMS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 35. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 36. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2026
FIGURE 38. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2026 (USD MILLION)
FIGURE 39. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 40. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, 2018-2026 (USD MILLION)
FIGURE 41. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 42. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2026 (USD MILLION)
FIGURE 43. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 44. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 45. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 47. ARGENTINA BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 48. BRAZIL BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 49. CANADA BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 50. MEXICO BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 51. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 52. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 53. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 55. AUSTRALIA BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 56. CHINA BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 57. INDIA BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 58. INDONESIA BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 59. JAPAN BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 60. MALAYSIA BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 61. PHILIPPINES BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 62. SINGAPORE BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 63. SOUTH KOREA BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 64. THAILAND BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 65. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 67. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 68. FRANCE BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 69. GERMANY BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 70. ITALY BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 71. NETHERLANDS BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 72. QATAR BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 73. RUSSIA BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 74. SAUDI ARABIA BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 75. SOUTH AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 76. SPAIN BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 77. UNITED ARAB EMIRATES BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 78. UNITED KINGDOM BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 79. GLOBAL BIOPROCESS VALIDATION MARKET: FPNV POSITIONING MATRIX
FIGURE 80. GLOBAL BIOPROCESS VALIDATION MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 81. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BIOPROCESS VALIDATION MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL BIOPROCESS VALIDATION MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY COMPATIBILITY TESTING SERVICES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY EXTRACTABLES/LEACHABLES TESTING SERVICES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY INTEGRITY TESTING SERVICES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY MICROBIOLOGICAL TESTING SERVICES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY BIOREACTORS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY FILTER ELEMENTS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY FREEZING AND THAWING PROCESS BAGS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY MEDIA CONTAINERS AND BAGS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY MIXING SYSTEMS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY TRANSFER SYSTEMS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 20. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 21. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 22. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 23. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 24. ARGENTINA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 25. ARGENTINA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 26. ARGENTINA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 27. BRAZIL BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 28. BRAZIL BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 29. BRAZIL BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 30. CANADA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 31. CANADA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 32. CANADA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 33. MEXICO BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 34. MEXICO BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 35. MEXICO BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 36. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 37. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 38. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 39. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 40. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 41. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 42. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 43. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 44. AUSTRALIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 45. AUSTRALIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 46. AUSTRALIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 47. CHINA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 48. CHINA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 49. CHINA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 50. INDIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 51. INDIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 52. INDIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 53. INDONESIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 54. INDONESIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 55. INDONESIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 56. JAPAN BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 57. JAPAN BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 58. JAPAN BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 59. MALAYSIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 60. MALAYSIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 61. MALAYSIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 62. PHILIPPINES BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 63. PHILIPPINES BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 64. PHILIPPINES BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 65. SINGAPORE BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 66. SINGAPORE BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 67. SINGAPORE BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 68. SOUTH KOREA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 69. SOUTH KOREA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 70. SOUTH KOREA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 71. THAILAND BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 72. THAILAND BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 73. THAILAND BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 78. FRANCE BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 79. FRANCE BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 80. FRANCE BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 81. GERMANY BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 82. GERMANY BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 83. GERMANY BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 84. ITALY BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 85. ITALY BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 86. ITALY BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 87. NETHERLANDS BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 88. NETHERLANDS BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 89. NETHERLANDS BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 90. QATAR BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 91. QATAR BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 92. QATAR BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 93. RUSSIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 94. RUSSIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 95. RUSSIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 96. SAUDI ARABIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 97. SAUDI ARABIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 98. SAUDI ARABIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 99. SOUTH AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 100. SOUTH AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 101. SOUTH AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 102. SPAIN BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 103. SPAIN BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 104. SPAIN BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 105. UNITED ARAB EMIRATES BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 106. UNITED ARAB EMIRATES BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 107. UNITED ARAB EMIRATES BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 108. UNITED KINGDOM BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2026 (USD MILLION)
TABLE 109. UNITED KINGDOM BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2026 (USD MILLION)
TABLE 110. UNITED KINGDOM BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 111. GLOBAL BIOPROCESS VALIDATION MARKET: SCORES
TABLE 112. GLOBAL BIOPROCESS VALIDATION MARKET: BUSINESS STRATEGY
TABLE 113. GLOBAL BIOPROCESS VALIDATION MARKET: PRODUCT SATISFACTION
TABLE 114. GLOBAL BIOPROCESS VALIDATION MARKET: RANKING
TABLE 115. GLOBAL BIOPROCESS VALIDATION MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 116. GLOBAL BIOPROCESS VALIDATION MARKET: MERGER & ACQUISITION
TABLE 117. GLOBAL BIOPROCESS VALIDATION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 118. GLOBAL BIOPROCESS VALIDATION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 119. GLOBAL BIOPROCESS VALIDATION MARKET: INVESTMENT & FUNDING
TABLE 120. GLOBAL BIOPROCESS VALIDATION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 121. GLOBAL BIOPROCESS VALIDATION MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Almac Group
  • BiOZEEN
  • Cobetter Filtration Equipment Co., Ltd.
  • Doc S.r.l
  • Eurofins Scientific
  • Hangzhou Anow Microfiltration Co., Ltd.
  • Meissner Filtration Products, Inc.
  • Merck KGaA
  • Pall Corporation
  • Porvair plc
  • Sartorius Stedim Biotech S.A.
  • SGS S.A.
  • Thermo Fisher Scientific, Inc
  • Tianshan Precision Filter Material Co., Ltd.
  • Toxikon Corporation
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll